MediXall Group, Inc. Share Price Other OTC
Equities
MDXL
US58504K1043
Advanced Medical Equipment & Technology
Sales 2021 | 15K 1.2M | Sales 2022 | 59.27K 4.73M | Capitalization | 77.59M 6.19B |
---|---|---|---|---|---|
Net income 2021 | -6M -478M | Net income 2022 | -6M -478M | EV / Sales 2021 | 7,599 x |
Net Debt 2021 | 252K 20.11M | Net Debt 2022 | 2.82M 225M | EV / Sales 2022 | 1,357 x |
P/E ratio 2021 |
-17
x | P/E ratio 2022 |
-10.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 85.16% |
Managers | Title | Age | Since |
---|---|---|---|
Travis Jackson
CEO | Chief Executive Officer | - | 13/06/22 |
Shane Glavin
DFI | Director of Finance/CFO | - | 12-05 |
Frank Dickerson
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
John Marino
CEO | Chief Executive Officer | 52 | 31/05/13 |
Travis Jackson
CEO | Chief Executive Officer | - | 13/06/22 |
Robert Hood
BRD | Director/Board Member | - | 09/10/23 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |